Light grey background with one-third of the Atomo circle in dark grey on the right hand side and a series of dark grey dots in the top right-hand corner

COVID-19 Tests

Atomo’s platform is a natural fit for a fast, accurate point of care diagnostic for COVID-19. Atomo offers an antigen test for the qualitative detection of nucleocapsid protein antigens specific to the SARS-CoV-2 virus with high accuracy and results in just 10 minutes.

COVID-19 Rapid Antigen Test

Sold in Australia & New Zealand
A fast, accurate point of care COVID-19 antigen test for the qualitative detection of nucleocapsid protein antigens specific to the SARS-CoV-2 virus.

3D rectangular box packaging with cassette, swab, cardboard holder and buffer solution bottle

Finished rapid test products are commercialised under Atomo's own brand or under private labels via partners and regional distributors. We hold regulatory approvals including CE Mark in the EU/ UK, Australian TGA, and the World Health Organization with FDA approvals pending.

Develop Future Tests With Us

Atomo’s unique technology presents an opportunity to improve existing products on the market with superior usability. Our integrated platforms can help users easily perform the tests on their own and improve performance, speed and reliability in a professional clinical setting.

We welcome dialogue with forward-thinking diagnostic partners who would like to explore co-developing tests for infectious diseases, allergy sensitivities, women’s health, men’s health, sexual health, heart health and other applications.

Man and woman sitting at desk looking at diagnostic test design on computer screen
Smiling woman leaning on the back of a smiling man in an outdoor setting with trees in the background

Re-imagining diagnostics.